NewsRadar
Home
Research
Products & Services
Online Data Service
Deals in Europe Report
Radar
Advanced Search
Add Company
Add Person
Customized Research
Weekly Newsletter
Online News
Events

PowderMed Ltd. (Acquired by Pfizer Inc.)
Developer of therapeutic DNA vaccines. Spin-off of Chiron Vaccines, a business unit of Chiron Corporation. The company acquired the rights to a powder mediated epidermal delivery (PMED) technology which it plans to use, in the first instance, in the development of therapeutic DNA vaccines in the areas of chronic viral diseases and cancer.

• Show past press releases
• Edit this company

CONTACT INFORMATION
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 		4 Robert Robinson Avenue
Oxford Science Park
Oxford OX4 4GA
United Kingdom
+44 (0)1865 501500
+44 (0)1865 501501
http://www.powdermed.com
Clive Dix
+44 (0)1865 501500

COMPANY FACTS
Founded:May 2004
Founders:
CEO:Clive Dix
CTO or technical lead:John Beadle
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:32
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:Yes

NON-EXECUTIVE BOARD MEMBERS

  • Rolf Stahel

    KEY CUSTOMERS

    KEY BUSINESS PARTNERS

  • Glaxo SmithKline
  • Ludwig Institute for Cancer Research
  • Lorantis

    KEY COMPETITORS

    CAPITAL RAISED
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    PUBLIC OFFERINGS
    DateTypeExchange
    No public offerings




    • Copyright © 1999-2010
    Test Publishing Limited. All rights reserved. Legal Information.